Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine

Recondo G Jr, de la Vega M, Galanternik F, Díaz-Cantón E, Leone BA, Leone JP

Cancer Management and Research 2016, 8:57-65

Published Date: 19 May 2016